Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026589 | SCV001189001 | likely benign | Hereditary cancer-predisposing syndrome | 2019-03-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001494971 | SCV001699638 | likely benign | Hereditary breast ovarian cancer syndrome | 2019-07-14 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268413 | SCV002551546 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Department of Clinical Genetics, |
RCV001026589 | SCV004801949 | likely benign | Hereditary cancer-predisposing syndrome | 2024-02-02 | criteria provided, single submitter | clinical testing | The following ACMG criteria is used: PM2_Supporting (not reported in gnomAD), BP4 (SpliceAI: less than or equal to 0.1), BP7 |